Botox Shows Promise for Dementia-Related Paratonia, Costs and Approvals Lag
TL;DR Summary
Canadian researchers report that botulinum toxin injections can ease paratonia in advanced dementia, reducing pain and easing caregiving for more than 100 patients, but the treatment is not Health Canada-approved for paratonia and costs around $12,000 per year, limiting access and highlighting the need for larger trials.
- Experimental treatment could ease ‘misunderstood’ dementia symptom - National Global News
- Baycrest Research Highlights Overlooked Condition Affecting People with Advanced Dementia Newswire Canada
- Paratonia remains underrecognized in advanced dementia care, research finds Benefits and Pensions Monitor
- Experimental treatment could ease ‘misunderstood’ dementia symptom unpublished.ca
- Patients suffering from dementia symptom, paratonia, may find relief in Botox Yahoo News Canada
Reading Insights
Total Reads
0
Unique Readers
29
Time Saved
18 min
vs 19 min read
Condensed
99%
3,661 → 47 words
Want the full story? Read the original article
Read on Global News